(Q39111267)

9 September 2017

title

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48. (English)

1 reference

9 September 2017

1 reference

1 reference

Gerretsen M

1

1 reference

9 September 2017

Visser GW

2

1 reference

9 September 2017

Brakenhoff RH

3

1 reference

9 September 2017

van Walsum M

4

1 reference

9 September 2017

Snow GB

5

1 reference

9 September 2017

van Dongen GA

6

1 reference

9 September 2017

publication date

1 January 1994

1 reference

9 September 2017

1 reference

9 September 2017

volume

24-25

1 reference

9 September 2017

page(s)

135-142

1 reference

Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02789224

Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02789224

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02789224

Development of a new in vivo model for head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02789224

Intraperitoneal radioimmunotherapy for ovarian cancer: pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies

21 January 2018

1 reference

12 December 2020

A brief guide to the practice of radioimmunoscintigraphy and radioimmunotherapy in cancer. Report of the European Association of Nuclear Medicine Task Group on the clinical utility of labelled antibodies

1 reference

12 December 2020

Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas

1 reference

12 December 2020

Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2

1 reference

12 December 2020

Radiation absorbed dose estimates at the cellular level for some electron-emitting radionuclides for radioimmunotherapy

1 reference

12 December 2020

Tumor size: effect on monoclonal antibody uptake in tumor models.

1 reference

12 December 2020

Beta dose point kernels for radionuclides of potential use in radioimmunotherapy.

1 reference

12 December 2020

186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.

1 reference

12 December 2020

186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.

1 reference

12 December 2020

Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.

1 reference

12 December 2020

A 22-kd surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified squamous and transitional epithelia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02789224

1 reference

9 September 2017

1 reference